Related references
Note: Only part of the references are listed.Heart failure with preserved ejection fraction: Squaring the circle between comorbidities and cardiovascular abnormalities
Alberto Maria Marra et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF-DRY-OFF study
C. Cogliati et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Heart failure with mid-range or mildly reduced ejection fraction
Gianluigi Savarese et al.
NATURE REVIEWS CARDIOLOGY (2022)
From mid-range to mildly reduced ejection fraction heart failure: A call to treat
Davide Stolfo et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation
Kristofor E. Glinton et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation
Mariantonia Braile et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Virginia S. Hahn et al.
CIRCULATION (2021)
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra et al.
NATURE REVIEWS CARDIOLOGY (2021)
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors
Leonardo Cristinziano et al.
CELLS (2021)
Mast Cells Are the Trigger of Small Vessel Disease and Diastolic Dysfunction in Diabetic Obese Mice
Sarah Guimbal et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis
Simone Marcella et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2021)
Angiopoietin inhibitors: A review on targeting tumor angiogenesis
Digna Parmar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment
Mariantonia Braile et al.
CELLS (2021)
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19
Alec A. Schmaier et al.
JCI INSIGHT (2021)
IL-11 in cardiac and renal fibrosis: Late to the party but a central player
Benjamin Corden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Asa K. Hedman et al.
HEART (2020)
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
Julio A. Chirinos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2in Ischemic and Non-Ischemic Heart Failure
Gilda Varricchi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Insight into the Pro-inflammatory and Profibrotic Role of Macrophage in Heart Failure With Preserved Ejection Fraction
Jin-lian Shen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction Results From the PROMIS-HFpEF Study
Sandra Sanders-van Wijk et al.
CIRCULATION (2020)
Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI
Wen Jian et al.
MEDICINE (2019)
Angiopoietin 1 influences ischemic reperfusion renal injury via modulating endothelium survival and regeneration
Wen-Chih Chiang et al.
MOLECULAR MEDICINE (2019)
Heart Failure With Preserved Ejection Fraction In Perspective
Marc A. Pfeffer et al.
CIRCULATION RESEARCH (2019)
Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019
Gilda Varricchi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Superantigenic Activation of Human Cardiac Mast Cells
Gilda Varricchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Giuseppe Sammarco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Nitrosative stress drives heart failure with preserved ejection fraction
Gabriele G. Schiattarella et al.
NATURE (2019)
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Racheal G. Akwii et al.
CELLS (2019)
Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide
Wen Jian et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
Identifying microRNAs and Their Editing Sites in Macaca mulatta
Qingyi Wang et al.
CELLS (2019)
Future Needs in Mast Cell Biology
Gilda Varricchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The effect of angiopoietin-1 upregulation on the outcome of acute ischaemic stroke in rodent models: A meta-analysis
Joseph Moxon et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Adrenomedullin in heart failure: pathophysiology and therapeutic application
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2018)
Innate effector cells in angiogenesis and lymphangiogenesis
Gilda Varricchi et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study
Annamaria Iorio et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Lars H. Lund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Cardiac macrophages promote diastolic dysfunction
Maarten Hulsmans et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Heart Failure with Preserved Ejection Fraction
James D. Gladden et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer
Gilda Varricchi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Hereditary angioedema: the plasma contact system out of control: comment
S. Loffredo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency
Stefania Loffredo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
Takeshi Suetomi et al.
CIRCULATION (2018)
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction The INDIE-HFpEF Randomized Clinical Trial
Barry A. Borlaug et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction
Seung-Jun Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study
A. Andrea Pozzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults The Atherosclerosis Risk in Communities Study
Amil M. Shah et al.
CIRCULATION (2017)
Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems
Lauri Eklund et al.
CLINICAL SCIENCE (2017)
Epidemiology of heart failure with preserved ejection fraction
Shannon M. Dunlay et al.
NATURE REVIEWS CARDIOLOGY (2017)
Therapeutic targeting of the angiopoietin-TIE pathway
Pipsa Saharinen et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
Manuel Fankhauser et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Group V Secreted Phosphapase A2 Induces the Release of Proanglogenic and Antianglogenic Factors by Human Neutrophils
Stefania Loffredo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
Rosaria I. Staiano et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema
S. Loffredo et al.
ALLERGY (2016)
Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease
Zhi-Yu Zeng et al.
CHINESE MEDICAL JOURNAL (2016)
Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction
Orianne Henri et al.
CIRCULATION (2016)
Predicting Heart Failure With Preserved and Reduced Ejection Fraction The International Collaboration on Heart Failure Subtypes
Jennifer E. Ho et al.
CIRCULATION-HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils
Teal S. Hallstrand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome
Chang-Qing Sun et al.
SCIENTIFIC REPORTS (2016)
Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the IABP-SHOCK II-Trial
Janine Poess et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Cardiac lymphatics are heterogeneous in origin and respond to injury
Linda Klotz et al.
NATURE (2015)
Heart Failure With Preserved Ejection Fraction Mechanisms, Clinical Features, and Therapies
Kavita Sharma et al.
CIRCULATION RESEARCH (2014)
Lymphangiogenic factors, mechanisms, and applications
Wei Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Steven A. Stacker et al.
NATURE REVIEWS CANCER (2014)
Emerging roles of secreted phospholipase A2 enzymes: An update
Makoto Murakami et al.
BIOCHIMIE (2013)
Circulating angiopoietins and cardiovascular mortality in cardiogenic shock
Andreas Link et al.
EUROPEAN HEART JOURNAL (2013)
Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population
Roberto Lorbeer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Ray E. Hershberger et al.
NATURE REVIEWS CARDIOLOGY (2013)
Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure
Alexander Lukasz et al.
PLOS ONE (2013)
AAV9-mediated VEGF-B Gene Transfer Improves Systolic Function in Progressive Left Ventricular Hypertrophy
Jenni Huusko et al.
MOLECULAR THERAPY (2012)
Circulating Angiopoietins-1 and-2, Angiopoietin Receptor Tie-2 and Vascular Endothelial Growth Factor-A as Biomarkers of Acute Myocardial Infarction: a Prospective Nested Case-Control Study
Carlos Iribarren et al.
BMC CARDIOVASCULAR DISORDERS (2011)
Angiopoietin-1 and -2 Exert Antagonistic Functions in Tumor Angiogenesis, yet Both Induce Lymphangiogenesis
Ernesta Fagiani et al.
CANCER RESEARCH (2011)
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Dirk Westermann et al.
CIRCULATION-HEART FAILURE (2011)
Epidemiology and clinical course of heart failure with preserved ejection fraction
Carolyn S. P. Lam et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Endothelial progenitor cell transplantation decreases lymphangiogenesis and adverse myocardial remodeling in a mouse model of acute myocardial infarction
Jae-Hyeong Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer
Petra Schulz et al.
FASEB JOURNAL (2011)
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
Marie Jeansson et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The role of mast cell-derived secreted phospholipases A2 in respiratory allergy
Francescopaolo Granata et al.
BIOCHIMIE (2010)
Pericytes are required for blood-brain barrier integrity during embryogenesis
Richard Daneman et al.
NATURE (2010)
Angiopoietin 2 and Cardiovascular Disease in Dialysis and Kidney Transplantation
Sascha David et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects
Aikaterini Detoraki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Lung mast cells are a source of secreted phospholipases A(2)
Massimo Triggiani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin
Sascha David et al.
JOURNAL OF HYPERTENSION (2009)
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension
Jeetesh V. Patel et al.
ANNALS OF MEDICINE (2008)
Biochemistry and physiology of mammalian secreted phospholipases A(2)
Gerard Lambeau et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Angiopoietins: a link between angiogenesis and inflammation
Ulrike Fiedler et al.
TRENDS IN IMMUNOLOGY (2006)
Expression and functions of the vascular endothelial growth factors and their receptors in human basophils
Amato de Paulis et al.
JOURNAL OF IMMUNOLOGY (2006)
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
U Fiedler et al.
NATURE MEDICINE (2006)
Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage
F Roviezzo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women - The EPIC-Norfolk Prospective Population study
SM Boekholdt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure
AY Chong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor Tie-2, and vascular endothelial growth factor levels in acute coronary syndromes
KW Lee et al.
CIRCULATION (2004)
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Paladebodies
U Fiedler et al.
BLOOD (2004)
Vascular endothelial growth factor-D expression in human atherosclerotic lesions
J Rutanen et al.
CARDIOVASCULAR RESEARCH (2003)
Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes
C Heeschen et al.
CIRCULATION (2003)
Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy
D Abraham et al.
CIRCULATION RESEARCH (2000)
Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions
JR Gamble et al.
CIRCULATION RESEARCH (2000)
Angiopoietin-1 protects the adult vasculature against plasma leakage
G Thurston et al.
NATURE MEDICINE (2000)
Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance
A Kranz et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
